NFGH
RETA
Nan Fung Group Holdings’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-3,300
| Closed | -$336K | – | 42 |
|
2023
Q2 | $336K | Buy |
+3,300
| New | +$336K | 0.22% | 32 |
|
2022
Q4 | – | Sell |
-8,265
| Closed | -$208K | – | 45 |
|
2022
Q3 | $208K | Hold |
8,265
| – | – | 0.13% | 32 |
|
2022
Q2 | $251K | Hold |
8,265
| – | – | 0.17% | 33 |
|
2022
Q1 | $271K | Hold |
8,265
| – | – | 0.13% | 37 |
|
2021
Q4 | $218K | Hold |
8,265
| – | – | 0.06% | 45 |
|
2021
Q3 | $832K | Hold |
8,265
| – | – | 0.27% | 23 |
|
2021
Q2 | $1.17M | Buy |
+8,265
| New | +$1.17M | 0.36% | 21 |
|